Compare CLOV & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLOV | NEOG |
|---|---|---|
| Founded | 2014 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | N/A | 1989 |
| Metric | CLOV | NEOG |
|---|---|---|
| Price | $2.58 | $5.95 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | $4.23 | ★ $8.83 |
| AVG Volume (30 Days) | ★ 5.4M | 3.4M |
| Earning Date | 11-04-2025 | 01-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,773,564,000.00 | $886,886,000.00 |
| Revenue This Year | $41.68 | N/A |
| Revenue Next Year | $37.69 | $1.80 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 32.15 | N/A |
| 52 Week Low | $2.12 | $3.87 |
| 52 Week High | $4.87 | $13.51 |
| Indicator | CLOV | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 47.73 | 48.44 |
| Support Level | $2.41 | $5.82 |
| Resistance Level | $2.72 | $6.08 |
| Average True Range (ATR) | 0.12 | 0.32 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 74.98 | 49.15 |
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.